# Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer

> **NCT00350142** · PHASE2 · COMPLETED · sponsor: **Albert Koong** · enrollment: 20 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **RADIATION:** Stereotactic Body Radiotherapy
- **DRUG:** Gemcitabine
- **OTHER:** 4D pancreatic protocol CT scan
- **RADIATION:** FDG PET scan

## Key facts

- **NCT ID:** NCT00350142
- **Lead sponsor:** Albert Koong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00350142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00350142, "Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00350142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*